Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters











Database
Publication year range
1.
Environ Manage ; 64(6): 783-793, 2019 Dec.
Article in English | MEDLINE | ID: mdl-31732774

ABSTRACT

Environmental Management Systems (EMS) based on international standard ISO 14001 are recognized as a tool to improve the environment and the sustainability of organizations. Green Chemistry (GC) seeks to reduce the use and generation of hazardous substances in chemical processes. This paper studies the relationship between EMS based on ISO 14001 and GC. We have analysed their similarities, difficulties, advantages, and synergies that can be developed with a joint implementation in general and in particular on university campuses. The results show that both disciplines have in common the philosophy of Continuous Improvement in the Processes (CIP) and that their joint application is possible, since each principle of GC are related to, at least, one clause of ISO 14001. It is shown that this joint application to different university areas can generate benefits, such as the reduction of hazardous waste and the promotion of green purchases, which favour the environmental improvement of universities. However, there are problems in their joint application related to the lack of specific knowledge and the difficulty of identifying products manufactured following the criteria of GC. Furthermore, a case study in the San Jorge University showing that both disciplines can be treated together is shown. Results were the following: seven GC initiatives (proposed by a small group of GC students) were submitted to the EMS office; only one was considered nonviable and two were implemented, achieving two main goals: Reduction of the environmental impact of laboratories and promotion of green purchasing in the laboratories of San Jorge University.


Subject(s)
Hazardous Waste , Universities , Commerce , Conservation of Natural Resources , Humans
2.
Rev Esp Quimioter ; 30(2): 96-102, 2017 Apr.
Article in Spanish | MEDLINE | ID: mdl-28211266

ABSTRACT

OBJECTIVE: The aim was to analyse those syndromes without fever in travellers who return from tropical regions evaluated at our Department of Infectology and Tropical Medicine. Clarifying these conditions intends to reach earlier diagnoses and, perhaps, to avoid the emergence and spread of imported diseases, as well as to establish appropriate preventive measures. METHODS: An observational descriptive transversal study was performed, selecting those patients who returned from tropical regions without fever (n = 281), amongst all travellers evaluated in our department between 1998 and 2013. We analysed demographic features, information related to the trip, as well as the presenting complaints and the diagnoses. RESULTS: A total of 281 international travellers presenting without fever were analysed. Only 39% had received health counsel prior to travelling. The most visited regions were Lat-in America (38.8%), Africa (37.8%) and Asia (13.6%). 15% of patients were asymptomatic or suffered from non-infectious conditions. Among the rest, most had either gastrointestinal (46%) or cutaneous (34%) syndromes. The main gastrointestinal condition was diarrhoea, with a microbiological diagnosis reached in almost 50% of cases. Regarding cutaneous syndromes, arthropods bites (31%) and different bacterial lesions (20%) were most common. CONCLUSIONS: Approximately 10% of patients in Travel Medicine are international travellers returning from tropical regions, half of them with no fever. Most are diagnosed with infectious diseases, mainly gastrointestinal or cutaneous syn-dromes. Eosinophilia is the third problem in frequency among this group of patients, and sexually transmitted infections are rare in our cohort. It is important to emphasize in preventive activities.


Subject(s)
Communicable Diseases/epidemiology , Travel , Tropical Medicine , Adult , Bacterial Infections/epidemiology , Bacterial Infections/microbiology , Communicable Diseases/microbiology , Female , Humans , Male , Risk Factors , Syndrome , Virus Diseases/epidemiology , Virus Diseases/microbiology
3.
Transplant Proc ; 43(6): 2257-9, 2011.
Article in English | MEDLINE | ID: mdl-21839250

ABSTRACT

BACKGROUND: Metabolic syndrome (MS) increases the risk of cardiovascular events due to endothelial dysfunction. There are few studies evaluating the impact of MS on the survival of heart transplantation (HTx) patients. AIM: The aim of this study was to study the impact of MS in the early period and on the long-term survival after HTx. MATERIALS AND METHODS: We studied 196 HTx patients with a minimum survival of 1 year post-HTx. A diagnosis of MS was made at 3 months after HTx, if at least 3 of the following criteria were met: triglyceride levels ≥150 mg/dL (or drug treatment for hypertriglyceridemia); high-density lipoprotein cholesterol (HDL-C) <40 mg/dL in men and <50 mg/dL in women (or drug treatment to raise HDL-C levels); diabetes mellitus on drug treatment or fasting glucose levels ≥100 mg/dL; blood pressure ≥130/85 mm Hg (or on antihypertensive drug treatment); and body mass index (BMI) ≥30. We used the Kaplan-Meier method (log-rank test) to calculate long-term survival and Student t and chi-square tests for comparisons. RESULTS: Among 196 patients, 96 developed MS. There were no differences between the groups with versus without MS in recipient gender, underlying etiology, smoking, pre-HTx diabetes, or immunosuppressive regimen. However, differences were observed between groups in age (MS: 53 ± 9 vs non-MS: 50 ± 12 years; P = .001); pre-HTx creatinine (MS: 1.2 ± 0.3 vs non-MS: 1.0 ± 0.4 mg/dL; P = .001); BMI (MS: 27.3 ± 4 vs non-MS: 24.6 ± 4; P = .001); pre-HTx hypertension (MS: 48% vs non-MS: 17%; P < .001); and dyslipidemia (MS: 53% vs non-MS: 37%; P = .023). Long-term survival was better among the non-MS group, but the difference did not reach significance (MS: 2381 ± 110 vs non-MS: 2900 ± 110 days; P = .34). CONCLUSIONS: The development of MS early after HTx is a common complication that affects nearly 50% of HTx patients. The prognostic implication of this syndrome on overall survival might occur in the long term.


Subject(s)
Heart Transplantation/adverse effects , Metabolic Syndrome/etiology , Biomarkers/blood , Blood Glucose/analysis , Blood Pressure , Body Mass Index , Chi-Square Distribution , Female , Heart Transplantation/mortality , Humans , Kaplan-Meier Estimate , Lipids/blood , Male , Metabolic Syndrome/blood , Metabolic Syndrome/diagnosis , Metabolic Syndrome/mortality , Metabolic Syndrome/physiopathology , Risk Assessment , Risk Factors , Spain , Time Factors , Treatment Outcome
4.
Presse Med ; 19(31): 1456-9, 1990 Sep 29.
Article in French | MEDLINE | ID: mdl-2146638

ABSTRACT

The cult of a slim body without the slightest bit of adipose tissue and the food restriction or selection habits it creates are extremely common in our society. Their influence on menstrual cycle and female infertility is not negligible. A vegetarian low calorie diet may induce cycle disorders and a short luteal phase. Disturbances in the pulsatility of gonadotropic hormones are responsible for anovulation, and they occur when slimness with excessive reduction of the body fat mass is associated with psycho-socio-professional stress factors or with intensive sporting activities. The greater frequency of dysovulation in obese women, notably those who put on weight rapidly, is accompanied by numerous hormonal changes, including reduced sex hormone-binding globulin, increased ovarian and adrenal androgen production, increased peripheral aromatization of androgens to oestrogens, and altered gonadotropin pulsatile secretion. The hyperinsulinism consecutive to insulin resistance in obese subjects might act as co-factor of the luteinizing hormone and as such participate in abnormalities of follicular maturation by stimulating the insulin-like growth factor and the ovarian androgens. However, the relative importance of these various factors in the physiopathology of abnormal ovulation remains to be determined. Overweight reduces the effectiveness of clomiphene citrate, menopausal gonadotropins and gonadotropin-releasing hormone in stimulating the follicles. Weight loss reduces hormonal disturbances and facilitates follicular maturation and ovulation in spontaneous or induced cycles.


Subject(s)
Feeding Behavior , Infertility, Female/physiopathology , Obesity/physiopathology , Weight Loss/physiology , Androgens/physiology , Female , Humans , Hypothalamic Hormones/physiology , Infertility, Female/diet therapy , Menstrual Cycle/physiology , Obesity/diet therapy
SELECTION OF CITATIONS
SEARCH DETAIL